Spero Therapeutics (SPRO)
(Delayed Data from NSDQ)
$1.30 USD
+0.01 (0.78%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $1.27 -0.03 (-2.31%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -0.47 |
EPS Last Quarter | -0.33 |
Last EPS Surprise | 5.71% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -1.59 |
Next Year | -1.54 |
EPS (TTM) | 0.41 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 10.00M | 10.20M | 39.70M | 56.00M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 10.00M | 10.20M | 39.70M | 56.00M |
Low Estimate | 10.00M | 10.20M | 39.70M | 56.00M |
Year ago Sales | 25.47M | 73.52M | 103.78M | 39.70M |
Year over Year Growth Est. | -60.74% | -86.13% | -61.75% | 41.06% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.47 | -0.42 | -1.59 | -1.54 |
# of Estimates | 2 | 1 | 3 | 2 |
Most Recent Consensus | -0.38 | -0.42 | -1.54 | -1.08 |
High Estimate | -0.38 | -0.42 | -1.38 | -1.08 |
Low Estimate | -0.55 | -0.42 | -1.70 | -1.99 |
Year ago EPS | 0.02 | 0.96 | 0.43 | -1.59 |
Year over Year Growth Est. | -2,450.00% | -143.75% | -469.77% | 3.46% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.47 | -0.42 | -1.59 | -1.54 |
7 Days Ago | -0.47 | -0.42 | -1.59 | -1.54 |
30 Days Ago | -0.47 | -0.42 | -1.59 | -1.54 |
60 Days Ago | -0.27 | -0.26 | -1.27 | -1.29 |
90 Days Ago | -0.27 | -0.26 | -1.27 | -1.29 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.47 | -0.42 | -1.59 | -1.54 |
Zacks Consensus Estimate | -0.47 | -0.42 | -1.59 | -1.54 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.33 | -0.24 | 0.96 | 0.02 | NA |
Estimate | -0.35 | -0.07 | -0.18 | -0.15 | NA |
Difference | 0.02 | -0.17 | 1.14 | 0.17 | 0.29 |
Surprise | 5.71% | -242.86% | 633.33% | 113.33% | 127.38% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more